GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial.

Saved in:
Bibliographic Details
Title: GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial.
Authors: Dan Dan Tian1, Bennett, Samuel K.2, Coupland, Lucy A.1, Forwood, Kathryn2, Lwin, Yadanar2, Pooryousef, Niloofar1, Tea, Illa1, Truong, Thy T.3, Neeman, Teresa4, Crispin, Philip2, D'Rozario, James2, Blackburn, Anneke C.1 anneke.blackburn@anu.edu.au
Source: Pharmacology Research & Perspectives. Dec2019, Vol. 7 Issue 6, p1-11. 11p.
Database: Academic Search Ultimate
Description
ISSN:20521707
DOI:10.1002/prp2.526